Literature DB >> 18593385

Guidelines for the management of basal cell carcinoma.

N R Telfer1, G B Colver, C A Morton.   

Abstract

This article represents a planned regular updating of the previous British Association of Dermatologists guidelines for the management of basal cell carcinoma. These guidelines present evidence-based guidance for treatment, with identification of the strength of evidence available at the time of preparation of the guidelines, and a brief overview of epidemiological aspects, diagnosis and investigation.

Entities:  

Mesh:

Year:  2008        PMID: 18593385     DOI: 10.1111/j.1365-2133.2008.08666.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  121 in total

1.  Liver kinase B1 (LKB1) in the pathogenesis of UVB-induced murine basal cell carcinoma.

Authors:  Yevgeniya A Byekova; Jennifer L Herrmann; Jianmin Xu; Craig A Elmets; Mohammad Athar
Journal:  Arch Biochem Biophys       Date:  2011-01-25       Impact factor: 4.013

Review 2.  Laser-assisted drug delivery in dermatology: from animal models to clinical practice.

Authors:  Faisal R Ali; Firas Al-Niaimi
Journal:  Lasers Med Sci       Date:  2015-12-22       Impact factor: 3.161

3.  Superficial Radiation Therapy for the Treatment of Nonmelanoma Skin Cancers.

Authors:  Sean McGregor; John Minni; David Herold
Journal:  J Clin Aesthet Dermatol       Date:  2015-12

4.  [Basal cell carcinoma of the periocular region].

Authors:  F Geszti; D Hargitai; O Lukáts; H Győrffy; J Tóth
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

Review 5.  Skin cancer - an overview for dentists.

Authors:  B J Steel
Journal:  Br Dent J       Date:  2014-05       Impact factor: 1.626

Review 6.  Fingolimod: a review of its use in relapsing-remitting multiple sclerosis.

Authors:  Mark Sanford
Journal:  Drugs       Date:  2014-08       Impact factor: 9.546

7.  Expression of matrix metalloproteinase-1, -9, -13, and tissue inhibitor of metalloproteinases-1 in basal cell carcinomas of the eyelid.

Authors:  Zornitsa I Zlatarova; Ekaterina B Softova; Klara G Dokova; Elisabeth M Messmer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-09-01       Impact factor: 3.117

8.  TGFβ, Fibronectin and Integrin α5β1 Promote Invasion in Basal Cell Carcinoma.

Authors:  François Kuonen; Isabelle Surbeck; Kavita Y Sarin; Monique Dontenwill; Curzio Rüegg; Michel Gilliet; Anthony E Oro; Olivier Gaide
Journal:  J Invest Dermatol       Date:  2018-07-14       Impact factor: 8.551

Review 9.  [Current diagnostics and therapy recommendations for ocular basal cell carcinoma].

Authors:  V Kakkassery; K U Loeffler; M Sand; K R Koch; A M Lentzsch; A C Nick; I A Adamietz; L M Heindl
Journal:  Ophthalmologe       Date:  2017-03       Impact factor: 1.059

10.  Evaluation of a Combined Reflectance Confocal Microscopy-Optical Coherence Tomography Device for Detection and Depth Assessment of Basal Cell Carcinoma.

Authors:  Aditi Sahu; Oriol Yélamos; Nicusor Iftimia; Miguel Cordova; Christi Alessi-Fox; Melissa Gill; Gopi Maguluri; Stephen W Dusza; Cristián Navarrete-Dechent; Salvador González; Anthony M Rossi; Ashfaq A Marghoob; Milind Rajadhyaksha; Chih-Shan J Chen
Journal:  JAMA Dermatol       Date:  2018-10-01       Impact factor: 10.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.